1800011I IDT biologika; to V5 obra--3 base task order funding; dmid carb can 8023349 $1,366,000
Ended Awarded
- Contract number
- 75N93019F00131
- Awardee
-
IDT Biologika GMBH UEI E14GD5J873N9
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,366,000
Award facts
- Opportunity
-
- RFPNIAIDDMIDNIHAI2017089 Solicitation number
- Manufacturing and Characterization Services for Vaccines and Other Biologics for Infectious Diseases Award Notice · Posted Jan 27, 2017
- Contract value 100% obligated
- $1,366,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Germany
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Modification | $1,366,000 | |
| Supplemental Agreement for work within scope | $0 |
About this award
This is a firm fixed-price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to IDT Biologika GMBH, a German biotechnology company. The $1,366,000 contract is for the development, manufacturing, and characterization of various biological materials to support infectious disease research and pandemic preparedness efforts, including influenza virus human challenge material, Staphylococcus aureus protein A, toxoid fusion proteins, and COVID-19 vaccine candidates. The contract is not associated with a set-aside program and does not identify any major subcontractors. The contract is part of NIAID's broader mission to conduct and support research to understand, treat, and prevent infectious diseases.
Quick answers
Who was awarded contract 75N93019F00131?
75N93019F00131 was awarded to IDT Biologika GMBH by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on April 11, 2019.
How much is contract 75N93019F00131 worth?
The government has obligated $1,366,000 on 75N93019F00131.
Is contract 75N93019F00131 an order under another contract?
Yes. 75N93019F00131 is a delivery order under 75N93018D00011, an indefinite delivery contract.
Was contract 75N93019F00131 competed?
The extent of competition for 75N93019F00131 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award